Stocks and Investing Stocks and Investing
Wed, April 15, 2020

Jeffrey Hung Maintained (APRE) at Hold with Increased Target to $780 on, Apr 15th, 2020


Published on 2024-10-27 02:56:56 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Maintained "Aprea Therapeutics, Inc." (APRE) at Hold with Increased Target from $720 to $780 on, Apr 15th, 2020.

Jeffrey, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources